2,091 followers
RT @SarcomaAlliance: This technical abstract describes screening 351 growth inhibiting drugs for activity in sarcoma cell lines. Chetomin,…
RT @SarcomaAlliance: This technical abstract describes screening 351 growth inhibiting drugs for activity in sarcoma cell lines. Chetomin,…
This technical abstract describes screening 351 growth inhibiting drugs for activity in sarcoma cell lines. Chetomin, CRM1/XPO1 inhibitors, and Actinomycin D (a standard drug for rhabdomyosarcoma)... https://t.co/T803YkPdsZ